Business
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Advertisement
Topic
Mounjaro
Business
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Health
Give more people weight-loss jabs on the NHS, say MPs
Current plans for 6% of eligible patients to get Mounjaro by 2028 unambitious, say MPs.
Business
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
Style
‘It’s problematic’: concern as weight-loss jab maker sponsors Vogue World event
Critics say partnership between Mounjaro maker Eli Lilly and fashion giant suggests thinness is an aspiration The fifth iteration of Vogue World, overseen by Anna Wintour, took place in Milan on Tuesday night. Gigi Hadid and Jennifer Lopez provided theatrics on the catwalk, but it was one of the event’s backers that caused the biggest stir. Eli Lilly, an American pharmaceutical company that manufactures a wide range of medicines, including weight-loss jabs Mounjaro and the Foundayo pill, was listed in the event credits as one of its “fashion adjacent” sponsors. Continue reading...
Science
Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive treatments for obesity and diabetes.
Science
Stopping Ozempic may raise heart attack and stroke risk
A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.
Science
AI uncovers hidden Ozempic side effects across 400,000 Reddit posts
AI analysis of 400,000 Reddit posts found that users of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound reported unexpected symptoms including menstrual changes, chills, hot flashes, and fatigue. Researchers cannot say the medications caused these problems, but the patterns may reveal overlooked signals worth studying.
Advertisement